Related Experiment Video

Updated: Jun 10, 2026

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
11:06

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques

Published on: May 2, 2017

Infectious diseases in end-stage liver disease patients

Aneesh K Mehta1, G Marshall Lyon

  • 1Division of Infectious Diseases, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 2101, 101 Woodruff Circle, Atlanta, GA 30322, USA. aneesh.mehta@emory.edu

Critical Care Nursing Clinics of North America
|August 10, 2010
PubMed

Insights

Patients with chronic liver disease have weakened immune systems, increasing bacterial infection risks. Early diagnosis and prompt treatment are crucial for better outcomes in these high-risk patients.

Area of Science:

  • Immunology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic liver diseases progressively impair patient immune systems.
  • Impaired host defense mechanisms elevate the risk of severe bacterial infections and morbidity.

Purpose of the Study:

  • To highlight the increased susceptibility to infections in chronic liver disease patients.
  • To emphasize the importance of vigilant infectious disease surveillance and early therapeutic interventions.

Main Methods:

  • Review of clinical presentations and risk factors for infections in chronic liver disease.
  • Emphasis on diagnostic approaches including cultures and peritoneal fluid analysis.
  • Importance of interdisciplinary consultation with infectious diseases specialists and microbiology labs.

Main Results:

  • Prompt recognition and management of infections are critical.
  • Early initiation of appropriate therapy significantly impacts patient prognosis.
  • Diagnostic cultures and expert consultation aid in optimizing treatment strategies.

Conclusions:

  • Heightened surveillance for infections is essential in patients with chronic liver disease.
  • A low threshold for diagnostic workup and consultation improves management of infectious complications.
  • Timely and accurate diagnosis maximizes therapeutic effectiveness in this vulnerable population.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...